Related references
Note: Only part of the references are listed.The combined effect of vitamin K and calcium on bone mineral density in humans: a meta-analysis of randomized controlled trials
Liyou Hu et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2021)
Effect of vitamin K2 on bone mineral density and serum cathepsin K in female osteoporosis patients
Gu Yuanyang et al.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH (2019)
Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials
A. Mott et al.
OSTEOPOROSIS INTERNATIONAL (2019)
New Aspects of Vitamin K Research with Synthetic Ligands: Transcriptional Activity via SXR and Neural Differentiation Activity
Yoshihisa Hirota et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Comparison of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03
Shiro Tanaka et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2017)
Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials
Z. -B. Huang et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Effects of risedronate alone or combined with vitamin K2 on serum undercarboxylated osteocalcin and osteocalcin levels in postmenopausal osteoporosis
Yuji Kasukawa et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2014)
Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women
Noriko Koitaya et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2014)
Prevention and treatment of postmenopausal osteoporosis
Sri Harsha Tella et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women
M. H. J. Knapen et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women
Toshiro Sato et al.
NUTRITION JOURNAL (2012)
Phylogenetic Analysis of Bacillus subtilis Strains Applicable to Natto (Fermented Soybean) Production
Yuji Kubo et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2011)
Osteoporosis: now and the future
Tilman D. Rachner et al.
LANCET (2011)
Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial
N. Emaus et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules
Tetsuo Inoue et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2009)
Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study
Masataka Shiraki et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2009)
Vitamin K Treatment Reduces Undercarboxylated Osteocalcin but Does Not Alter Bone Turnover, Density, or Geometry in Healthy Postmenopausal North American Women
Neil Binkley et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Effect of Low Dose Vitamin K2 (MK-4) Supplementation on Bio-Indices in Postmenopausal Japanese Women
Noriko Koitaya et al.
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2009)
Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis
P. J. Meunier et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women
Makoto Hirao et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2008)
Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells
T. Ichikawa et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2007)
Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women
M. H. J. Knapen et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia
Y Purwosunu et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2006)
Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study
Y Ishida et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Effect of continuous combined therapy with vitamin K2 and vitamin D3 on bone mineral density and coagulofibrinolysis function in postmenopausal women
T Ushiroyama et al.
MATURITAS (2002)
Treatment of calcium-channel-blocker intoxication with insulin infusion.
EW Boyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Vitamin K-2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis
M Shiraki et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Effect of vitamin K-2 on osteoblast apoptosis: Vitamin K-2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine
S Urayama et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2000)
Share Paper
